Physician profile
Michael O Mcbride
NPI 1235161977
$1,946.52
in general payments reported to CMS, 2019-2025
11 companies · $271 in 2025
The $271 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $219 · 2021: $588 · 2022: $151 · 2023: $203 · 2024: $344 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $817.48 | 2019-2024 | Mitris Resilia Mitral Valve |
| Atricure, INC. | $615.81 | 2021-2025 | Synergy Ablation System |
| Kls-Martin L.P. | $161.57 | 2020-2024 | |
| Medtronic, INC. | $98.54 | 2021-2025 | Avalus, Corevalve Evolut R |
| Stryker Corporation | $68.72 | 2024-2025 | Na |
| W. L. Gore & Associates, INC. | $53.63 | 2019-2021 | |
| Baxter Healthcare | $30.29 | 2021-2024 | Floseal |
| Abbott Laboratories | $30.09 | 2020 | |
| Biomerieux INC | $29.79 | 2019 | |
| Shockwave Medical, INC | $21.66 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Ethicon US, LLC | $18.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcbride listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.